Skip to main content
Premium Trial:

Request an Annual Quote

STMicroelectronics and MobiDiag in Deal to Develop Infectious Disease Detection Biochip

NEW YORK, Oct. 29 (GenomeWeb News) - STMicroelectronics and MobiDiag announced today an agreement to jointly develop a MEMS biochip for genomic-based infectious disease detection.

 

The companies did not disclose the financial terms of the agreement.

 

"The ST/MobiDiag solution will reduce the cost and complexity of the diagnosis by producing consumables that will be very competitive and offer superior performance compared to existing solutions," the companies said in a statement.

 

STMicroelectronics, a Geneva-based, publicly traded semiconductor company, has developed a disposable silicon MEMS chip that uses PCR to perform DNA amplification and detection of DNA sequence. The channels in the silicon act microfluidically to carry the sample and reagents and resistive heating elements control temperature, according to the company.

MobiDiag, of Helsinki, Finland, specializes in biochip-based molecular diagnostics of infectious diseases. The company has developed the ability to analyze and manage microbial genomic data to design panels for clinical diagnosis of microbial pathogens, according to its website.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.